Pretransplant treatments for hepatocellular carcinoma: They improve outcomes?

Liver Transplantation

Volumn 11, Issue 11 SUPPL. 2, 2005, Pages

  Di Bisceglie, Adrian M ^a  

^a Saint Louis University   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; ANTINEOPLASTIC AGENT;

ARTICLE; CHEMOEMBOLIZATION; CLINICAL TRIAL; EVIDENCE BASED MEDICINE; HUMAN; LIVER CELL CARCINOMA; LIVER RESECTION; MULTIMODALITY CANCER THERAPY; POSTOPERATIVE PERIOD; PREOPERATIVE TREATMENT; PRIORITY JOURNAL; PROSPECTIVE STUDY; RADIOFREQUENCY ABLATION; RANDOMIZATION; TREATMENT OUTCOME; TUMOR GROWTH; TUMOR RECURRENCE;

CARCINOMA, HEPATOCELLULAR; CATHETER ABLATION; CHEMOEMBOLIZATION, THERAPEUTIC; HEPATECTOMY; HUMANS; LIVER NEOPLASMS; LIVER TRANSPLANTATION; TREATMENT OUTCOME;

EID: 30444438216     PISSN: 15276465     EISSN: None     Source Type: Journal    
DOI: 10.1002/lt.20598     Document Type: Article

References (16)

1. Befeler A, Hayashi P, Di Bisceglie A. Liver transplantation for hepatocellular carcinoma. Gastroenterology 2005;128:1752-1764.
2. Hover J, Real M, Montanya X, Planas R, Coll S, Aponte A, et al. Arterial embolization, chemoembolization versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomized controlled trial. Lancet 2002;359:1734-1739.
3. Mazzaferro V, Regalia E, Doci R, Andreola S, Pulvirenti A, Bozzetti F, et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med 1996;334:693-699.
4. Sotiropoulos G, Malago M, Molmenti E, Paul A, Nadalin S, Brokalaki E, et al. Efficacy of trans-arterial chemoembolization prior to liver transplantataion for hepatocellular carcinoma as found in pathology. Hepatogastroenterology 2005;62:329-332.
5. Cheng Y, Huang T, Chen T, Chen Y, Wang C, Hsu S, et al. Impact of pre-operative transaterial embolization on the treatment of hepatocellular carcinoma with liver transplantation. World J Gastroenterol 2005;11:1433-1438.
6. Ravaioli M, Grazi GL, Ercolani G, Fiorentino M, Cescon M, Golfieri R, et al. Partial necrosis on hepatocellular carcinoma nodules facilitates tumor recurrence after liver transplantation. Transplantation 2004;78:1780-1786.
7. Mazzaferro V, Battiston C, Perrone S, Pulvirenti S, Regalia E, Romito R, et al. Radiofrequency ablation of small hepatocellular carcinoma in cirrhotic patients awaiting liver transplantation: a prospective study. Ann Surg 2004;240:900-909.
8. Lu D, Yu N, Raman S, Lassman C, Tong MJ, Britten C, et al. Percutaneous radiofrequency ablation of hepatocellular carcinoma as a bridge to liver transplantation. Hepatology 2005;41: 1130-1137.
9. Belghiti J, Cortes A, Abdalla E, Regimbeau JM, Prakash K, Durand F, et al. Resection prior to liver transplantation for hepatocellular carcinoma. Ann Surg 2003;238:885-893.
10. Adam R, Azoulay D, Castaing D, Eshkenazy R, Pascal G, Hashizume K, et al. Liver resection as a bridge to transplantation for hepatocellular carcinoma on cirrhosis: a reasonable strategy? Ann Surg 2003;238:508-519.
11. Hu RH, Ho MC, Wu YM, Yu SC, Lee PH. Feasibility of salvage liver transplantation for patients with recurrence hepatocellular carcinoma. Clin Transplant 2005;19:175-180.
12. Fisher R, Maluf D, Cotterell A, Stravitz T, Wolfe L, Luketic V, et al. Non-resective ablation therapy for hepatocellular carcinoma: effectiveness measured by intention-to-treat and dropout from liver transplant waiting list. Clin Transplant 2004;18:502-512.
13. Porrett P, Sonnad S, Timmins K, Rosen M, Soulen M, Shaked A, et al. Retransplant locoregional ablative therapy for HCC may nopt provide beneficial effect in the current MELD era. Hepatology 2004;40:194A.
14. Lee J, Chu I, Heo J, Calvisi D, Sun Z, Roskams T, et al. Classification and prediction of survival in hepatocellular carcinoma by gene expression profiling. Hepatology 2004;40:667-676.
15. Marsh J, Finkelstein S, Demetris A, Swalsky P, Sasatomi E, Bandos A, et al. Genotyping of hepatocellular carcinoma in the liver transplant recipients adds predictive power for determining recurrence-free survival. Liver Transplant 2003;9:664-671.
16. Yao F, Kinkhabwala M, LaBerge J, Bass N, Brown R, Kerlan R, et al. The impact of pre-operative loco-regional therapy on outcome after liver transplantation for hepatocellular carcinoma. Am J Transplant 2005;5:795-804.